Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans.
By E. Brunetti, P. Kern, D. Vuitton. Acta Tropica, 2010
1,997 citations recorded by the source corpus.
The earlier recommendations of the WHO-Informal Working Group on Echinococcosis (WHO-IWGE) for the treatment of human echinococcosis have had considerable impact in different settings worldwide, but the last major revision was published more than 10 years ago. Advances in classification and treatment of echinococcosis prompted experts from different continents to review the current literature, discuss recent achievements and provide a consensus on diagnosis, treatment and follow-up. Among the recognized species, two are of medical importance -Echinococcus granulosus and Echinococcus multilocularis - causing cystic echinococcosis (CE) and alveolar echinococcosis (AE), respectively. For CE, consensus has been obtained on an image-based, stage-specific approach, which is helpful for choosing one of the following options: (1) percutaneous treatment, (2) surgery, (3) anti-infective drug treatment or (4) watch and wait. Clinical decision-making depends also on setting-specific aspects. The usage of an imaging-based classification system is highly recommended. For AE, early diagnosis and radical (tumour-like) surgery followed by anti-infective prophylaxis with albendazole remains one of the key elements. However, most patients with AE are diagnosed at a later stage, when radical surgery (distance of larval to liver tissue of >2cm) cannot be achieved. The backbone of AE treatment remains the continuous medical treatment with albendazole, and if necessary, individualized interventional measures. With this approach, the prognosis can be improved for the majority of patients with AE. The consensus of experts under the aegis of the WHO-IWGE will help promote studies that provide missing evidence to be included in the next update.
Subfields: Infectious Diseases, Pathology and Forensic Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/b462f31a7e1b04a17ab1adebc74526ec526c15c9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- H. Wen
- L. Vuitton
- T. Tuxun
- Jun Li
- D. McManus
- D. Vuitton
- Wenbao Zhang
- Isheng. J. Tsai
Citations in the corpus
- Chapter 1. General introduction (2015, neutral): “Selective arterial embolisation for ruptured HCAs may be a valuable alternative although it has rarely been reported [55, 63, 70, 72, 87].”
- The genomes of four tapeworm species reveal adaptations to parasitism (2013, background): “Uniquely, tapeworms and flukes have merged two key enzymatic functions for redox homeostasis in one single enzyme: thioredoxin glutathione reductase (TGR).”
- Echinococcosis: Advances in the 21st Century (2019, methodology): “PAIR has definitely become part of the interventional therapeutic options in CE for midsized CE1 and CE3a cysts (63) (Fig.”